Literature DB >> 2383548

An unusual specificity in the activation of neutrophil serine proteinase zymogens.

G Salvesen1, J J Enghild.   

Abstract

The majority of proteinases exist as zymogens whose activation usually results from a single proteolytic event. Two notable exceptions to this generalization are the serine proteinases neutrophil elastase (HNE) and cathepsin G (cat G), proteolytic enzymes of human neutrophils that are apparently fully active in their storage granules. On the basis of amino acid sequences inferred from the gene and cDNAs encoding these enzymes, it is likely that both are synthesized as precursors containing unusual C-terminal and N-terminal peptide extensions absent from the mature proteins. We have used biosynthetic radiolabeling and radiosequencing techniques to identify the kinetics of activation of both proteinases in the promonocyte-like cell line U937. We find that both N- and C-terminal extensions are removed about 90 min after the onset of synthesis, resulting in the activation of the proteinases. HNE and cat G are, therefore, transiently present as zymogens, presumably to protect the biosynthetic machinery of the cell from adventitious proteolysis. Activation results from cleavage following a glutamic acid residue to give an activation specificity opposite to those of almost all other serine proteinase zymogens, but shared, possibly, by the "granzyme" group of related serine proteinases present in the killer granules of cytotoxic T-lymphocytes and rat mast cell proteinase II.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2383548     DOI: 10.1021/bi00474a013

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  10 in total

1.  Cathepsin H is an additional convertase of pro-granzyme B.

Authors:  Michael E D'Angelo; Phillip I Bird; Christoph Peters; Thomas Reinheckel; Joseph A Trapani; Vivien R Sutton
Journal:  J Biol Chem       Date:  2010-04-30       Impact factor: 5.157

2.  The 1.8 A crystal structure of human cathepsin G in complex with Suc-Val-Pro-PheP-(OPh)2: a Janus-faced proteinase with two opposite specificities.

Authors:  P Hof; I Mayr; R Huber; E Korzus; J Potempa; J Travis; J C Powers; W Bode
Journal:  EMBO J       Date:  1996-10-15       Impact factor: 11.598

3.  Neutrophil elastase and cathepsin G protein and messenger RNA expression in bone marrow from a patient with Chediak-Higashi syndrome.

Authors:  D Burnett; C J Ward; R A Stockley; R G Dalton; A J Cant; S Hoare; J Crocker
Journal:  Clin Mol Pathol       Date:  1995-02

4.  Neutrophil lysosomal dysfunctions in mutant C57 Bl/6J mice: interstrain variations in content of lysosomal elastase, cathepsin G and their inhibitors.

Authors:  C Gardi; E Cavarra; P Calzoni; P Marcolongo; M de Santi; P A Martorana; G Lungarella
Journal:  Biochem J       Date:  1994-04-01       Impact factor: 3.857

5.  Papillon-Lefèvre syndrome patient reveals species-dependent requirements for neutrophil defenses.

Authors:  Ole E Sørensen; Stine N Clemmensen; Sara L Dahl; Ole Østergaard; Niels H Heegaard; Andreas Glenthøj; Finn Cilius Nielsen; Niels Borregaard
Journal:  J Clin Invest       Date:  2014-09-17       Impact factor: 14.808

6.  Neutrophil elastase, an acid-independent serine protease, facilitates reovirus uncoating and infection in U937 promonocyte cells.

Authors:  Joseph W Golden; Leslie A Schiff
Journal:  Virol J       Date:  2005-05-31       Impact factor: 4.099

7.  Complementary LC-MS/MS-Based N-Glycan, N-Glycopeptide, and Intact N-Glycoprotein Profiling Reveals Unconventional Asn71-Glycosylation of Human Neutrophil Cathepsin G.

Authors:  Ian Loke; Nicolle H Packer; Morten Thaysen-Andersen
Journal:  Biomolecules       Date:  2015-08-12

8.  Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity.

Authors:  S S Tolsma; O V Volpert; D J Good; W A Frazier; P J Polverini; N Bouck
Journal:  J Cell Biol       Date:  1993-07       Impact factor: 10.539

9.  Residual active granzyme B in cathepsin C-null lymphocytes is sufficient for perforin-dependent target cell apoptosis.

Authors:  Vivien R Sutton; Nigel J Waterhouse; Kylie A Browne; Karin Sedelies; Annette Ciccone; Desiree Anthony; Aulikki Koskinen; Arno Mullbacher; Joseph A Trapani
Journal:  J Cell Biol       Date:  2007-02-05       Impact factor: 10.539

10.  Cystatin F is a cathepsin C-directed protease inhibitor regulated by proteolysis.

Authors:  Garth Hamilton; Jeff D Colbert; Alexander W Schuettelkopf; Colin Watts
Journal:  EMBO J       Date:  2008-02-06       Impact factor: 11.598

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.